Cerity Partners LLC Guardant Health, Inc. Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 195,008 shares of GH stock, worth $9.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

195,008

Previous 126,125 54.61%

Holding current value

$9.16 Million

Previous $3.64 Million 22.76%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$22.3 - $36.29 $1.54 Million - $2.5 Million	68,883 Added 54.61%	195,008 $4.47 Million
Q2 2024 Aug 13, 2024	SELL	$16.07 - $31.84 $1 Million - $1.98 Million	-62,334 Reduced 33.08%	126,125 $3.64 Million
Q1 2024 May 14, 2024	BUY	$17.13 - $26.91 $2.38 Million - $3.74 Million	138,817 Added 279.64%	188,459 $3.89 Million
Q4 2023 Jan 26, 2024	BUY	$21.58 - $29.5 $742,093 - $1.01 Million	34,388 Added 225.44%	49,642 $1.34 Million
Q3 2023 Nov 13, 2023	SELL	$25.8 - $39.97 $1.19 Million - $1.85 Million	-46,258 Reduced 75.2%	15,254 $452,000
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $361,550 - $656,280	17,266 Added 39.02%	61,512 $2.2 Million
Q1 2023 May 11, 2023	BUY	$22.92 - $33.76 $302,039 - $444,889	13,178 Added 42.42%	44,246 $1.04 Million
Q4 2022 Feb 15, 2023	BUY	$25.44 - $59.78 $240,026 - $564,024	9,435 Added 43.61%	31,068 $845,000
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $275,800 - $385,337	6,317 Added 41.24%	21,633 $1.17 Million
Q2 2022 Aug 10, 2022	SELL	$28.82 - $77.35 $47,149 - $126,544	-1,636 Reduced 9.65%	15,316 $618,000
Q1 2022 Apr 25, 2022	BUY	$48.25 - $100.49 $73,291 - $152,644	1,519 Added 9.84%	16,952 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $16,500 - $22,399	186 Added 1.22%	15,433 $1.54 Million
Q3 2021 Oct 25, 2021	BUY	$98.77 - $132.17 $11,161 - $14,935	113 Added 0.75%	15,247 $1.91 Million
Q2 2021 Aug 11, 2021	BUY	$109.77 - $165.68 $13,391 - $20,212	122 Added 0.81%	15,134 $1.88 Million
Q1 2021 Aug 11, 2021	BUY	$127.04 - $179.1 $96,677 - $136,295	761 Added 5.34%	15,012 $2.29 Million
Q1 2021 May 12, 2021	SELL	$127.04 - $179.1 $25,153 - $35,461	-198 Reduced 1.37%	14,251 $2.18 Million
Q4 2020 Feb 11, 2021	SELL	$99.96 - $135.93 $33,786 - $45,944	-338 Reduced 2.29%	14,449 $1.86 Million
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $1.19 Million - $1.65 Million	14,787 New	14,787 $1.65 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $849,059 - $1.21 Million	-13,279 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$34.3 - $97.98 $455,469 - $1.3 Million	13,279 New	13,279 $1.02 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.8B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Guardant Health, Inc. Transaction History